FIA
AGN

FNY Investment Advisers’s Allergan plc AGN Stock Holding History

FNY Investment Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-103,984
Closed -$18.4M – 683
2020
Q1 		$18.4M Buy
103,984
+24,269
+30% +$4.57M 14.01% 1
2019
Q4 		$15.2M Sell
79,715
-44,433
-36% -$8.02M 4.72% 3
2019
Q3 		$20.9M Buy
124,148
+116,505
+1,524% +$19M 6.39% 2
2019
Q2 		$1.28M Buy
+7,643
New +$1.06M 0.38% 36

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

FNY Investment Advisers's AGN Position: Q2 2020 in Review

FNY Investment Advisers sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 103,984 shares — an estimated $18.4M sold.

FNY Investment Advisers first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $20.9M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • FNY Investment Advisers reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 103,984 Allergan plc shares in Q2 2020, an estimated $18.4M.
  • FNY Investment Advisers first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • FNY Investment Advisers's Allergan plc position peaked at $20.9M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on FNY Investment Advisers's 13F filing for Q2 2020, filed 10 Jul 2020.